Alimentary Tract| Volume 53, ISSUE 7, P846-851, July 2021

Download started.


Low prevalence of colorectal neoplasia in microscopic colitis: A large prospective multi-center study

Published:October 28, 2020DOI:


      Background and Aims

      Microscopic colitis (MC) is the most frequent condition in subjects undergoing ileocolonoscopy for chronic non-bloody diarrhea (CNBD) in Western countries. Emerging evidence has shown a negative association between MC and colorectal cancer. Within this prospective multi-center study we have evaluated the risk of colorectal neoplasia in MC and non-MC patients with CNBD receiving ileocolonoscopy with high-definition plus virtual chromoendoscopic imaging and histopathological assessment.


      Patients with CNBD of unknown origin were prospectively enrolled in 5 referral centers in Northern Italy for ileocolonoscopy with high-definition and digital/optical chromoendoscopy plus multiple biopsies in each segment. The prevalence of colorectal neoplasia (cancer, adenoma, serrated lesion) in MC was compared to that observed in a control group including CNBD patients negative for MC, inflammatory bowel disease or eosinophilic colitis.


      From 2014 and 2017, 546 consecutive CNBD patients were recruited. Among the 492 patients (mean age 53±18 years) fulfilling the inclusion criteria against the exclusion critieria, MC was the predominant diagnosis at histopathological assessment (8.7%: N=43, 28 CC, 15 LC). The regression model adjusted for age and gender showed a significant negative association between the diagnosis of CM and colorectal neoplasia (OR=0.39; 95% CI 0.22−0.67, p <0.001) with a 60% decreased risk of adenomatous and neoplastic serrated polyps as compared to the control group (n=412).


      This multi-center study confirms MC as a low-risk condition for colorectal neoplasia. No surveillance colonoscopy program is to be performed for MC diagnosis.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Digestive and Liver Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Münch A
        • et al.
        Microscopic colitis: current status, present and future challenges: statements of the European microscopic colitis group.
        J Crohn's Colitis. 2012; 6: 932-945
        • Temmerman F.
        • Baert F
        Collagenous and lymphocytic colitis: systematic review and update of the literature.
        Dig Dis. 2010; 27: 137-145
        • Fernández-Bañares F
        • et al.
        Current concepts on microscopic colitis: evidence-based statements and recommendations of the Spanish microscopic colitis group.
        Aliment Pharmacol Ther. 2016;
        • Miehlke S
        • et al.
        Microscopic colitis: pathophysiology and clinical management.
        Lancet Gastroenterol Hepatol. 2019;
        • Langner C
        • et al.
        Histology of microscopic colitis-review with a practical approach for pathologists.
        Histopathology. 2015; 66: 613-626
        • Guagnozzi D.
        • Lucendo A.J.
        • Angueira-Lapeña T.
        • González-Castillo S.
        • Tenias Burillo J.M.
        Prevalence and incidence of microscopic colitis in patients with diarrhoea of unknown aetiology in a region in central Spain.
        Dig Liver Dis. 2012; 44: 384-388
        • Gentile N.M.
        • Yen E.F.
        The incidence of microscopic colitis: microscopic no more.
        Dig Dis Sci. 2017; 62: 1394-1395
        • Thijs W.J.
        • van Baarlen J.
        • Kleibeuker J.H.
        • Kolkman J.J.
        Microscopic colitis: prevalence and distribution throughout the colon in patients with chronic diarrhoea.
        Neth J Med. 2005; 63: 137-140
        • Nyhlin N.
        • Bohr J.
        • Eriksson S.
        • Tysk C.
        Systematic review: microscopic colitis.
        Aliment Pharmacol Ther. 2006; 23: 1525-1534
        • Pardi D.S
        • et al.
        The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota.
        Gut. 2007; 56: 504-508
        • Fernández-Bañares F
        • et al.
        Incidence of collagenous and lymphocytic colitis: a 5-year population- based study.
        Am J Gastroenterol. 1999; 94: 418-423
        • Verhaegh B.P.M
        • et al.
        Incidence of microscopic colitis in the Netherlands. A nationwide population-based study from 2000 to 2012.
        Dig Liver Dis. 2015; 47: 30-36
        • Bergman D
        • et al.
        A nationwide cohort study of the incidence of microscopic colitis in Sweden.
        Aliment Pharmacol Ther. 2019;
        • Guagnozzi D.
        • Tontini G.E.
        • Pastorelli L.
        Editorial: the increasing burden of microscopic colitis.
        Aliment Pharmacol Ther. 2019;
        • Williams J.J.
        • Beck P.L.
        • Andrews C.N.
        • Hogan D.B.
        • Storr M.A.
        Microscopic colitis - a common cause of diarrhoea in older adults.
        Age Ageing. 2010; 39: 162-168
        • Vigren L
        • et al.
        Is smoking a risk factor for collagenous colitis?.
        Scand J Gastroenterol. 2011; 46: 1334-1339
        • Fernández-Bañares F
        • et al.
        Impact of current smoking on the clinical course of microscopic colitis.
        Inflamm Bowel Dis. 2013; 19: 1470-1476
        • Pascua M.F
        • et al.
        Microscopic colitis and medication use.
        Clin Med Insights Gastroenterol. 2010; 3: 11-19
        • Yen E.F
        • et al.
        Decreased colorectal cancer and adenoma risk in patients with microscopic colitis.
        Dig Dis Sci. 2012; 57: 161-169
        • Kao K.-T
        • et al.
        Microscopic colitis: a large retrospective analysis from a health maintenance organization experience.
        World J Gastroenterol. 2009; 15: 3122-3127
        • Tontini G.E
        • et al.
        Microscopic colitis and colorectal neoplastic lesion rate in chronic nonbloody diarrhea: a prospective, multicenter study.
        Inflamm Bowel Dis. 2014; 20: 882-891
        • Kaltenbach T.
        • McQuaid K.R.
        • Soetikno R.
        • Laine L.
        Improving detection of colorectal dysplasia in inflammatory bowel disease surveillance.
        Gastrointest Endosc. 2016; 83: 1013-1014
        • Sebastian S
        • et al.
        Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I).
        J Crohn's Colitis. 2014; 8: 5-18
        • Xie J.
        • Itzkowitz S.H.
        Cancer in inflammatory bowel disease.
        World J Gastroenterol. 2008;
        • Ullman T.A.
        • Itzkowitz S.H
        Intestinal inflammation and cancer.
        Gastroenterology. 2011;
        • Chan J.L
        • et al.
        Cancer risk in collagenous colitis.
        Inflamm Bowel Dis. 1999; 5: 40-43
        • Sonnenberg A.
        • Genta R.M.
        Low prevalence of colon polyps in chronic inflammatory conditions of the colon.
        Am J Gastroenterol. 2015;
        • Levy A
        • et al.
        Cancer risk in microscopic colitis: a retrospective cohort study.
        BMC Gastroenterology. 2019;
        • Shen B
        • et al.
        The role of endoscopy in the management of patients with diarrhea.
        Gastrointest Endosc. 2010;
        • Borsotti E
        • et al.
        Terminal ileum ileoscopy and histology in patients undergoing high-definition colonoscopy with virtual chromoendoscopy for chronic nonbloody diarrhea: a prospective, multicenter study.
        United Eur Gastroenterol J. 2019;
        • Arasaradnam R.P
        • et al.
        Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition.
        Gut. 2018;
        • Magro F
        • et al.
        European consensus on the histopathology of inflammatory bowel disease.
        J Crohn's Colitis. 2013; 7: 827-851
        • Zammit S.C
        • et al.
        Eosinophilic gastrointestinal disorder: is it what it seems to be?.
        Ann Gastroenterol. 2018;
        • Valori R
        • Rey J-F
        • Atkin W
        • et al.
        European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition–quality assurance in endoscopy in colorectal cancer screening and diagnosis.
        Endoscopy. 2012; 44: SE88-S105
        • Cotton P.B.
        • et al.
        A lexicon for endoscopic adverse events: report of an ASGE workshop.
        Gastrointest Endosc. 2010; 71: 446-454
        • Ferlitsch M
        • et al.
        Colorectal polypectomy and endoscopic mucosal resection (EMR): European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline.
        Endoscopy. 2017;
        • Villanacci V.
        • Casella G.
        • Bassotti G.
        The spectrum of drug-related colitides: important entities, though frequently overlooked.
        Dig Liver Dis. 2011; 43: 523-528
        • Jass J.R.
        Classification of colorectal cancer based on correlation of clinical, morphological and molecular features.
        Histopathology. 2007; 50: 113-130
        • Rex D.K
        • et al.
        Serrated lesions of the colorectum: review and recommendations from an expert panel.
        Am J Gastroenterol. 2012; 107: 1315-1329
        • Delavari A
        • et al.
        Mean polyp per patient is an accurate and readily obtainable surrogate for adenoma detection rate: results from an opportunistic screening colonoscopy program.
        Middle East J Dig Dis. 2015; 7: 214-219
        • Team, R. C. R
        A language and environment for statistical computing.
        R Foundation for Statistical Computing, 2016
        • Pardi D.S.
        Microscopic colitis: an update.
        Inflamm Bowel Dis. 2004; 10: 860-870
        • Shah R.J.
        • Fenoglio-Preiser C.
        • Bleau B.L.
        • Giannella R.A.
        Usefulness of colonoscopy with biopsy in the evaluation of patients with chronic diarrhea.
        Am J Gastroenterol. 2001; 96: 1091-1095
        • Pardi D.S.
        Diagnosis and management of microscopic colitis.
        Am J Gastroenterol. 2016;
        • Sonnenberg A.
        • Genta R.M
        Lymphocytic and collagenous colitis: epidemiologic differences and similarities.
        Dig Dis Sci. 2013;
        • Tontini G.E.
        • Vecchi M.
        • Pastorelli L.
        • Neurath M.F.
        • Neumann H.
        Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives.
        World J Gastroenterol. 2015; 21: 21-46
        • Vesely M.D.
        • Kershaw M.H.
        • Schreiber R.D.
        • Smyth M.J
        Natural innate and adaptive immunity to cancer.
        Annu Rev Immunol. 2011;
        • Rex D.K
        • et al.
        Quality indicators for GI endoscopic procedures.
        Am J Gastroenterol. 2015;
        • Loreau J
        • Duricova D
        • et al.
        Long-term natural history of microscopic colitis: a population-based cohort.
        Clin Transl Gastroenterol. 2019; 10: e00071
        • Larsson JK
        • Dabos KJ
        • et al.
        Cancer risk in collagenous colitis.
        J Clin Med. 2019; 8 (1942. doi:10.3390)
        • Sipos F.
        • Constantinovits M.
        • Muzes G.
        Intratumoral functional heterogeneity and chemotherapy.
        World J Gastroenterol. 2014;
        • Andresen L
        • et al.
        Activation of nuclear factor kB in colonic mucosa from patients with collagenous and ulcerative colitis.
        Gut. 2005;